Your browser is no longer supported. Please, upgrade your browser.
NEW! We've added Bitcoin charts to our Forex section. ×
Settings
ENDP [NASD]
Endo International plc
IndexS&P 500 P/E- EPS (ttm)-0.98 Insider Own0.60% Shs Outstand178.75M Perf Week-0.02%
Market Cap15.19B Forward P/E16.32 EPS next Y5.21 Insider Trans0.00% Shs Float175.11M Perf Month-9.66%
Income-134.20M PEG- EPS next Q1.03 Inst Own99.50% Short Float5.88% Perf Quarter-1.53%
Sales3.00B P/S5.07 EPS this Y-4.70% Inst Trans4.09% Short Ratio4.18 Perf Half Y22.28%
Book/sh24.40 P/B3.48 EPS next Y14.49% ROA-3.20% Target Price94.63 Perf Year17.94%
Cash/sh2.12 P/C40.13 EPS next 5Y9.07% ROE-12.20% 52W Range57.14 - 96.58 Perf YTD17.86%
Dividend- P/FCF36.78 EPS past 5Y-33.10% ROI-7.70% 52W High-11.92% Beta1.18
Dividend %- Quick Ratio1.40 Sales past 5Y14.50% Gross Margin48.80% 52W Low48.88% ATR2.59
Employees5062 Current Ratio1.50 Sales Q/Q51.70% Oper. Margin19.40% RSI (14)46.37 Volatility3.59% 3.02%
OptionableYes Debt/Eq1.34 EPS Q/Q322.50% Profit Margin-12.00% Rel Volume0.69 Prev Close85.00
ShortableYes LT Debt/Eq1.30 EarningsMay 11 BMO Payout- Avg Volume2.46M Price85.07
Recom1.90 SMA20-0.87% SMA50-4.82% SMA20011.80% Volume624,813 Change0.08%
May-22-15Reiterated Cantor Fitzgerald Hold $80 → $92
Apr-16-15Reiterated Piper Jaffray Overweight $102 → $110
Apr-13-15Reiterated Deutsche Bank Buy $91 → $96
Mar-03-15Reiterated RBC Capital Mkts Outperform $80 → $98
Feb-02-15Reiterated CRT Capital Fair Value $73 → $80
Jan-30-15Reiterated Deutsche Bank Buy $81 → $91
Sep-02-14Initiated RBC Capital Mkts Outperform $80
Aug-01-14Reiterated Stifel Buy $75 → $84
Jun-27-14Initiated Canaccord Genuity Buy $83
Apr-30-14Initiated National Alliance Securities Buy $76
Mar-04-14Reiterated FBR Capital Mkt Perform $52 → $82
Mar-03-14Reiterated UBS Buy $75 → $90
Nov-06-13Upgrade Needham Underperform → Hold
Nov-06-13Reiterated Stifel Buy $40 → $60
Oct-30-13Initiated FBR Capital Mkt Perform $40
Sep-20-13Reiterated UBS Buy $43 → $50
Jun-21-13Resumed Oppenheimer Perform
Jun-06-13Reiterated UBS Buy $39 → $41
Jun-06-13Reiterated Stifel Buy $36 → $40
Jun-06-13Downgrade Cantor Fitzgerald Hold → Sell $36 → $30
May-21-15 06:05AM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Se
May-20-15 08:00AM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
May-19-15 02:16PM  7 Biotech Stocks Moving Off The UBS Healthcare Conference
11:01AM  Pharma buying spree continues
10:10AM  Company News for May 19, 2015 - Corporate Summary
10:05AM  Fed afraid of everything: LaVorgna
09:34AM  Jim Cramer -- Stock Market's Takeover Frenzy Won't End Anytime Soon at TheStreet
09:30AM  DKS has a golf problem: Cramer
09:14AM  Story Stocks from Briefing.com Briefing.com
07:30AM  First Ever Peyronie's Disease (PD) Treatment Guidelines Support Use of XIAFLEX® in Appropriate Patients PR Newswire
07:30AM  First Ever Peyronie's Disease (PD) Treatment Guidelines Support Use of XIAFLEX® in Appropriate Patients CNW Group
12:41AM  Overheard: For Bankers, a Means to an Endo at The Wall Street Journal
12:38AM  [$$] Endo to Buy Par Pharma for About $8 Billion at The Wall Street Journal
12:18AM  PRESS DIGEST- New York Times business news - May 19 Reuters
May-18-15 08:31PM  PRESS DIGEST- Financial Times - May 19 Reuters -5.37%
08:03PM  Drug Deal to Generate Tax Benefits at The Wall Street Journal
06:56PM  Ann and Endo big market movers
05:45PM  Stock Pops & Drops: WB, ENDP, SWKS & GMCR
05:22PM  For Bankers, a Means to an Endo -- Overheard at The Wall Street Journal
04:57PM  Endo International (ENDP) Expands Generics with $8 Billion Par Pharma Buy - Stocks in the News
04:54PM  Endo Vaults Into Top 5 Among Generic-Drug Firms
04:54PM  Endo Buying Par Pharma To Become Top Generics Player at Investor's Business Daily
04:30PM  Stocks End Higher; S&P 500, Dow Hit New Record Highs
04:15PM  Drug Takeover Valuations Soar as Par Pharma Gains 300%: Real M&A at Bloomberg
04:05PM  Endo Buys Par Pharma for $8.05 Billion Amid Hunt for Deals
03:54PM  For Bankers, a Means to an Endo at The Wall Street Journal
03:05PM  Endo Finance Co. -- Moody's reviews Endo's ratings for downgrade at Moody's
02:49PM  Endo buying Par for $8B in push for generics, higher profit
02:32PM  Endo buying Par for $8 billion in a big generics push at Los Angeles Times
02:15PM  US STOCKS-Dow, S&P hit record highs as rate-hike worries fade
01:50PM  S&P 500, Dow Hit Intraday Records as Apple Grinds Higher at TheStreet
01:33PM  Inside the Endo Deal to Buy Par Pharma for $8.05B at Bloomberg
01:04PM  US STOCKS-Dow, S&P touch record highs
12:57PM  Endo buying Par for $8 billion in a big generics push
12:02PM  Endo Buys Par Pharmaceutical for $8.05B to Expand in U.S. Generics at TheStreet
12:00PM  Stocks Modestly Higher
11:41AM  Endo buys Par Pharma for $8B to expand generics at USA TODAY
11:17AM  [video]Stocks Trade Flat; Icahn Says Apple Remains 'Undervalued' at TheStreet
10:59AM  US STOCKS-Wall St down as homebuilder confidence slips
10:35AM  Endo International: Is Par a Good Fit? at Barrons.com
10:10AM  Endo Int'l. (ENDP) Stock Declines After $8 Billion Purchase of Par Pharmaceutical at TheStreet
09:50AM  US STOCKS-Wall St opens mixed ahead of homebuilder sentiment data
09:14AM  Endo buying generic drug maker for $8B at bizjournals.com
09:11AM  Stock Futures Step Back as Oil Prices Climb at TheStreet
09:04AM  ANN soars on Ascena buyout; Altera, Intel talks back on?; Endo buys Par
08:33AM  The pharma M&A party is still in full swing, as Endo snaps up Par at Fortune
08:14AM  Investors' hangover; Target's health food kick; AMC's new dawn
08:08AM  Endo buying Par in $8.05 billion cash-and-stock deal
08:02AM  Endo buys Par from TPG for $8.05 billion
08:01AM  Housing, inflation data set to dominate Wall Street at CNBC
07:59AM  Endo to buy Par Pharma for about $8 billion at MarketWatch
07:55AM  Ann soars on takeover bid; Eleven Biotherapeutics falls on failed trial at MarketWatch
07:55AM  May 18 Premarket Briefing: 10 Things You Should Know
07:53AM  Early movers: ENDP, ANN, BABA, INTC, COP & more at CNBC
07:30AM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:10AM  10 things you need to know before the opening bell
07:04AM  Endo Acquiring Par Pharmaceuticals in $8.05B Deal at Bloomberg
06:58AM  Endo agrees to buy Par Pharmaceutical in $8 billion deal at MarketWatch
06:43AM  Endo International to buy Par Pharmaceuticals for $8.05 bln Reuters
06:30AM  Endo to Acquire Par Pharmaceutical, Strategically Expanding Generics Business to a Top 5 Industry Leader PR Newswire
06:30AM  Endo to Acquire Par Pharmaceutical, Strategically Expanding Generics Business to a Top 5 Industry Leader CNW Group
06:14AM  Endo gets big vote of confidence
May-16-15 01:04PM  ENDO INTERNATIONAL PLC Financials
May-15-15 05:38PM  Endo Announces Updated XIAFLEX® Label with Recurrence and Retreatment Data in Patients with Dupuytren's Contracture PR Newswire
05:38PM  Endo Announces Updated XIAFLEX® Label with Recurrence and Retreatment Data in Patients with Dupuytren's Contracture CNW Group
03:35PM  Endo/BioDelivery Reveal Encouraging Data on Pain Drug - Analyst Blog
May-14-15 04:26PM  Top New Picks of Healthcare Fund Blue Jay Capital: Endo International plc (ENDP), Alkermes Plc (ALKS), Akorn Inc. (AKRX) at Insider Monkey
04:05PM  Endo Pharmaceuticals and BioDelivery Sciences Present Pivotal Data from Two Phase 3 Trials Demonstrating Safety and Efficacy of Buprenorphine HCl Buccal Film for the Management of Chronic Pain PR Newswire
04:05PM  Endo Pharmaceuticals and BioDelivery Sciences Present Pivotal Data from Two Phase 3 Trials Demonstrating Safety and Efficacy of Buprenorphine HCl Buccal Film for the Management of Chronic Pain CNW Group
07:30AM  Endo Employees Participate in 2nd Annual "Endo Gives" Day of Volunteering, Serving the Communities Where They Live and Work PR Newswire
07:30AM  Endo Employees Participate in 2nd Annual "Endo Gives" Day of Volunteering, Serving the Communities Where They Live and Work CNW Group
May-12-15 12:54PM  Leerink Is Changing Targets At These 7 Biotechs
10:10AM  Company News for May 12, 2015 - Corporate Summary
May-11-15 06:36PM  Actavis Earnings Strong, Gives 2015 Guidance
04:04PM  Endo Int'l. (ENDP) Stock Declined Despite Earnings Beat at TheStreet
03:13PM  Endo (ENDP) Beats on Q1 Earnings, 2015 Guidance Upped - Analyst Blog
02:46PM  Endo International (ENDP) Earnings Report: Q1 2015 Conference Call Transcript at TheStreet
11:10AM  S.Africa's Aspen sells part of local unit to Endo for $134 mln
09:00AM  Endo International PLC Earnings Call scheduled for 9:00 am ET today
08:35AM  Endo International Tops Profit Views at The Wall Street Journal
08:22AM  Endo (ENDP) Beats on Q1 Earnings, 2015 Guidance Updated - Tale of the Tape
07:54AM  Endo misses Street 1Q forecasts
07:30AM  Endo Acquires Broad Portfolio of Branded and Generic Products, Expanding International Pharmaceuticals Business PR Newswire
07:30AM  Endo Acquires Broad Portfolio of Branded and Generic Products, Expanding International Pharmaceuticals Business CNW Group
07:08AM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Results of Operations and Financial Condition
07:07AM  Q1 2015 Endo International PLC Earnings Release - Before Market Open
07:00AM  Endo Reports First Quarter 2015 Financial Results CNW Group
07:00AM  BioDelivery Sciences Provides Corporate Update and Reports First Quarter 2015 Financial Results PR Newswire
May-08-15 04:57PM  Dow Leads Market Gains; NYSE Winners Top Losers 4-1 at Investor's Business Daily
04:40PM  Will Endo International's (ENDP) Q1 Earnings Disappoint? - Analyst Blog
May-07-15 01:00PM  Abuse of Pain Pills Fuels Viruss Spread, Confounding Regulators at Bloomberg
May-06-15 11:09AM  Endo Announces Appearance at UBS Global Healthcare Conference at noodls
09:00AM  Endo Announces Appearance at UBS Global Healthcare Conference PR Newswire
09:00AM  Endo Announces Appearance at UBS Global Healthcare Conference CNW Group
May-05-15 06:45AM  What's buying put buying in Endo
May-01-15 04:13PM  15 Companies Losing the Most Money
Apr-30-15 06:04PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Change in Directors or Principal Officers
Apr-29-15 06:58AM  Valeant Boosts 2015 Outlook as Results Top Views at The Wall Street Journal
Apr-28-15 08:00AM  Endo Announces Appointment of Matthew J. Maletta as Chief Legal Officer PR Newswire
08:00AM  Endo Announces Appointment of Matthew J. Maletta as Chief Legal Officer CNW Group
Endo International plc, a specialty healthcare company, focuses on branded and generic pharmaceuticals and devices worldwide. It operates through four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices, and International Pharmaceuticals. The U.S. Branded Pharmaceuticals segment provides various branded prescription products, including Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Fortesta Gel, Supprelin LA, Valstar, Vantas, Sumavel DosePro, Aveed, and Natesto to treat and manage pain and conditions in urology, endocrinology, and oncology. The U.S. Generic Pharmaceuticals segment offers products in the pain management, urology, CNS disorders, immunosuppression, oncology, women's health, hypertension, generic lidocaine patch, and other markets. The Devices segment provides various medical devices comprising AMS 800 artificial urinary sphincters, AMS 700 MS series, Monarc subfascial hammock products, Elevate anterior and posterior pelvic floor repair systems, and GreenLight XPS laser systems in the areas of men's and women's pelvic health. The International Pharmaceuticals segment offers Dexedrine, Tridural, Metadol, Trandate, Pennsaid, and Plan B products in therapeutic areas, including attention deficit hyperactivity disorder, pain, urology, and allergy. It sells its branded pharmaceuticals and generics directly to large pharmacy chains; and through wholesale drug distributors to pharmacies, hospitals, governmental agencies, and physicians. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.